Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

Delayed Quote. Delayed  - 07/27 04:59:38 pm
377.8 DKK   -0.89%
07/25 NOVO NORDISK A/ : - Share repurchase programme
07/23 NOVO NORDISK A/ : 66% of diabetes sufferers unaware
07/21 NOVO NORDISK A/ : The Digital Health Connection in Africa
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
07/21/2016 07/22/2016 07/25/2016 07/26/2016 07/27/2016 Date
372.6(c) 375(c) 370.5(c) 381.2(c) 377.8 Last
1 806 250 952 518 1 603 246 2 366 741 1 722 356 Volume
-0.21% +0.64% -1.20% +2.89% -0.89% Change
More quotes
Financials ( DKK)
Sales 2016 114 729 M
EBIT 2016 49 673 M
Net income 2016 38 845 M
Finance 2016 10 619 M
Yield 2016 1,89%
Sales 2017 123 601 M
EBIT 2017 53 859 M
Net income 2017 42 554 M
Finance 2017 13 334 M
Yield 2017 2,11%
P/E ratio 2016 24,74
P/E ratio 2017 22,22
EV / Sales2016 6,59x
EV / Sales2017 6,10x
Capitalization 767 189 M
More Financials
Company
Novo Nordisk AS engages in the research, development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes and Obesity Care; and Biopharmaceuticals segments.The Diabetes and Obesity Care segment covers insulins, glucagon-like-peptide 1, other protein-related... 
Sector
Pharmaceuticals
Calendar
08/05Earnings Release
More about the company
Surperformance© ratings of Novo Nordisk A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVO NORDISK A/S
07/25 NOVO NORDISK A/S : - Share repurchase programme
07/23 NOVO NORDISK A/S : 66% of diabetes sufferers unaware
07/21 NOVO NORDISK A/S : Researchers at Novo Nordisk Report New Data on Stem Cell Rese..
07/21 NOVO NORDISK A/S : The Digital Health Connection in Africa
07/18 NOVO NORDISK A/S : - Share repurchase programme
07/14 NOVO NORDISK A/S : Unique New Book Series from Novo Nordisk and JDRF Uses Custom..
07/12 NOVO NORDISK A/S : to present 28 abstracts at the World Federation of Hemophilia..
07/11 NOVO NORDISK A/S : - Share repurchase programme
07/07 NOVO NORDISK A/S : Inc. Partners with Tony Award®-Winning Actor and Entertainer ..
07/07 NOVO NORDISK A/S : Findings on Hormones Reported by Investigators at Novo Nordis..
More news
Sector news : Pharmaceuticals - NEC
10:22aDJBAYER : Reports Higher Second-Quarter Profit, Raises Guidance -- Update
08:55aDJBAYER : Second-Quarter Profit Rises
08:37aDJBAYER : Second-Quarter Profit Rises 18.6%
08:35aDJBAYER : Second-Quarter Profit Rises 18.6%
07/26 Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/25 RETIREMENT STRATEGY : 5 Pharmaceutical Dividends To Buy Here
07/21 The End Of Another Chapter In Obesity Drug Development
07/20 Vivus Begins Q3 With Underwhelming Qsymia Sales
07/19 Arena - Belviq Scripts Start Q3 In Tough Shape
07/18 Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2016 Update
Advertisement
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 32
Average target price 402  DKK
Spread / Average Target 5,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Lars Rebien Sørensen President & Chief Executive Officer
Göran Albert Ando Chairman
Jesper Brandgaard Chief Financial Officer & Executive Vice President
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Alan C. Moses Global Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK A/S-7.35%113 407
JOHNSON & JOHNSON21.84%344 243
PFIZER INC.14.10%223 368
NOVARTIS AG-5.30%219 971
ROCHE HOLDING LTD.-9.99%218 902
MERCK & CO., INC.10.49%161 542
More Results